Technical analysis of Black Diamond Therapeutics, Inc. (BDTX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Black Diamond Therapeutics, Inc. is a biotechnology enterprise dedicated to discovering, advancing, and bringing to market therapeutic agents specifically designed for patients with genetically characterized tumors. A core part of its pipeline is BDTX-189, an irreversible small molecule inhibitor.
Price Performance
| 1 month | -5.83% |
| 3 months | +16.87% |
| Year-to-date | -20.16% |
| 1 year | -38.61% |
| 3 years | -44.57% |
52-Week Range
| 52-week High | $4.94 |
| 52-week Low | $1.60 |
| Avg Volume (90d) | 1.3M |
Technical Indicators
| SMA 50 | $1.97 |
| SMA 200 | $2.33 |
| Beta | 3.39 |
| 30-day Volatility (annualised) | 51.5% |
| Price vs SMA 50 | -1.3% |
| Price vs SMA 200 | -16.8% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $3.87 | |
| 2025-11 | $3.82 | -1.3% |
| 2025-12 | $2.43 | -36.4% |
| 2026-01 | $2.49 | +2.5% |
| 2026-02 | $2.47 | -0.8% |
| 2026-03 | $2.13 | -13.8% |
| 2026-04 | $2.65 | +24.4% |
| 2026-05 | $2.22 | -16.2% |
| 2026-06 | $1.85 | -16.7% |
| 2026-07 | $1.69 | -8.6% |
| 2026-08 | $2.10 | +24.3% |
| 2026-09 | $1.94 | -7.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $0.18 | $557M |
| 2026-09-14 | | $144M |
| 2026-09-14 | $0.03 | $3M |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
Price
| Price | $1.94 |
| Market Cap | $111M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.15 |
| EV / EBITDA | -2.92 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.18 |
| Current Ratio | 7.28 |